SPONSOR
Aligos Therapeutics
Total Trials
2
Recruiting
2
Phases
Phase 1
NCT07342881 Phase 1
Recruiting
Single Dose Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Pevifoscorvir Sodium (ALG-000184) in Participants With Renal Impairment and in Healthy Participants With Normal Renal Function
Chronic Hepatitis B Infection
NCT07342868 Phase 1
Recruiting
Single-Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Pevifoscorvir Sodium (ALG-000184) in Subjects With Moderate Hepatic Impairment and in Healthy Subjects With Normal Hepatic Function
Chronic Hepaititis B Infections